| Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma S Mellid, E Gil, R Letón, E Caleiras, E Honrado, S Richter, N Palacios, ... Frontiers in Endocrinology 13, 1070074, 2023 | 7 | 2023 |
| The effects of caffeine intake on cardiovascular parameters in sleep deprived medical residents IR Papacocea, IA Badarau, MC Ciornei, SL Burciulescu, MT Papacocea Rev Chim 70, 1445-1448, 2019 | 7 | 2019 |
| Clinical presentation of sporadic and hereditary pheochromocytoma/paraganglioma SML Burciulescu, C Randon, F Duprez, W Huvenne, D Creytens, ... Endocrine Oncology 3 (1), 2023 | 4 | 2023 |
| Pheochromocytoma-paraganglioma: translational approach from genetics to clinical neuroendocrinology S Lider, M Gheorghiu Acta Endocrinologica (Bucharest) 14 (4), 570, 2018 | 3 | 2018 |
| Bilateral pheochromocytomas: clinical presentation and morbidity rate related to surgery technique and genetic status SML Burciulescu, ML Gheorghiu, A Muresan, I Gherlan, A Patocs, ... Endocrine Connections 13 (4), 2024 | 1 | 2024 |
| Malignant Paraganglioma Non-Responsive to MIBG In MEN2A Syndrome S Lider, M Gheorghiu, I Milos, C Badiu Acta Endocrinologica (Bucharest) 18 (4), 536, 2022 | 1 | 2022 |
| The role of ambulatory blood pressure monitoring in the diagnosis of pheochromocytoma. S Lider, C Badiu Journal of Hypertension Research 7 (4), 131-135, 2020 | 1 | 2020 |
| Genetic landscape of Romanian PPGLs SM Lider‐Burciulescu, M Gheorghiu, E Braha, LS Stanescu, A Patocs, ... Journal of Cellular and Molecular Medicine 28 (23), e70204, 2024 | | 2024 |
| A case of silent giant pheochromocytoma SM Lider-Burciulescu, C Stancu, M Anghel, V Radulescu, C Badiu Endocrine Abstracts 99, 2024 | | 2024 |
| Factors that influence pheochromocytoma penetrance in MEN2A Syndrome SM Lider-Burciulescu, ML Gheorghiu, A Muresan, S Laura-Semonia, ... Endocrine Abstracts 99, 2024 | | 2024 |
| Challenges and pitfalls in the management of medullary thyroid cancer-Real-life data from a tertiary center in Romania S Laura-Semonia, A Muresan, D Ioachim, SM Lider-Burciulescu, M Băetu, ... Endocrine Abstracts 99, 2024 | | 2024 |
| New possible pathogenic variants involved in pheochromocytomas and paragangliomas SML Burciulescu, ML Gheorghiu, A Patocs, EE Braha, C Badiu Endocrine Abstracts 93, 2023 | | 2023 |
| Bilateral pheochromocytomas-recurrence and adrenal insufficiency rate related to surgical technique and genetic status SM Lider-Burciulescu, ML Gheorghiu, T Victor, C Badiu Endocrine Abstracts 90, 2023 | | 2023 |
| Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma R Leton, F Maletta, E Rapizzi, E Honrado, MA Galvez, M Calatayud, ... | | 2023 |
| Adipose tissue and glycemic changes in patients with surgically treated acromegaly GM Livia, PA Maria, LBS Maria, M Purice, C Iordachescu Endocrine Abstracts 86, 2022 | | 2022 |
| Advances in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas in the Era of Personalized Genetic Diagnostic SML Burciulescu, ML Gheorghiu IntechOpen, 2022 | | 2022 |
| Characteristics of patients with life-threatening events in pheochromocytoma SM Lider-Burciulescu, ML Gheorghiu, C Badiu Endocrine Abstracts 81, 2022 | | 2022 |
| Hyperandrogenism and breast cancer in a postmenopausal woman-treatment challenges BSM Lider, A Dumitrascu, S Vladoiu, A Caragheorgheopol, ML Gheorghiu Endocrine Abstracts 74, 2021 | | 2021 |
| Rapid decrease of a pituitary mass with gonadotrophic and thyrotrophic insufficiency–the case for lymphocytic hypophysitis? GM Livia, AB Irina, MLB Sofia, D Anda, A Ramona Endocrine Abstracts 73, 2021 | | 2021 |
| Characteristics of pheochromocytomas/paragangliomas in Flemish population MLB Sofia, C Badiu, L Bruno Endocrine Abstracts 73, 2021 | | 2021 |
